270 related articles for article (PubMed ID: 23733406)
21. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
Hanieh H
Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
[TBL] [Abstract][Full Text] [Related]
22. The aryl hydrocarbon receptor promotes inflammation-induced dedifferentiation and systemic metastatic spread of melanoma cells.
Mengoni M; Braun AD; Gaffal E; Tüting T
Int J Cancer; 2020 Nov; 147(10):2902-2913. PubMed ID: 32790916
[TBL] [Abstract][Full Text] [Related]
23. Expression of the aryl hydrocarbon receptor is not required for the proliferation, migration, invasion, or estrogen-dependent tumorigenesis of MCF-7 breast cancer cells.
Spink BC; Bennett JA; Lostritto N; Cole JR; Spink DC
Mol Carcinog; 2013 Jul; 52(7):544-54. PubMed ID: 22388733
[TBL] [Abstract][Full Text] [Related]
24. The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells.
Stanford EA; Wang Z; Novikov O; Mulas F; Landesman-Bollag E; Monti S; Smith BW; Seldin DC; Murphy GJ; Sherr DH
BMC Biol; 2016 Mar; 14():20. PubMed ID: 26984638
[TBL] [Abstract][Full Text] [Related]
25. Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.
Zhang S; Kim K; Jin UH; Pfent C; Cao H; Amendt B; Liu X; Wilson-Robles H; Safe S
Mol Cancer Ther; 2012 Jan; 11(1):108-18. PubMed ID: 22034498
[TBL] [Abstract][Full Text] [Related]
26. The aryl hydrocarbon receptor, a basic helix-loop-helix transcription factor of the PAS gene family, is required for normal ovarian germ cell dynamics in the mouse.
Robles R; Morita Y; Mann KK; Perez GI; Yang S; Matikainen T; Sherr DH; Tilly JL
Endocrinology; 2000 Jan; 141(1):450-3. PubMed ID: 10614669
[TBL] [Abstract][Full Text] [Related]
27. The Aryl Hydrocarbon Receptor Undergoes Chaperone-Mediated Autophagy in Triple-Negative Breast Cancer Cells.
Chen J; Yang Y; Russu WA; Chan WK
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562118
[TBL] [Abstract][Full Text] [Related]
28. Reactivation of estrogen receptor α by vorinostat sensitizes mesenchymal-like triple-negative breast cancer to aminoflavone, a ligand of the aryl hydrocarbon receptor.
Stark K; Burger A; Wu J; Shelton P; Polin L; Li J
PLoS One; 2013; 8(9):e74525. PubMed ID: 24058584
[TBL] [Abstract][Full Text] [Related]
29. Aryl hydrocarbon receptor counteracts pharmacological efficacy of doxorubicin via enhanced AKR1C3 expression in triple negative breast cancer cells.
Yamashita N; Kanno Y; Saito N; Terai K; Sanada N; Kizu R; Hiruta N; Park Y; Bujo H; Nemoto K
Biochem Biophys Res Commun; 2019 Aug; 516(3):693-698. PubMed ID: 31253396
[TBL] [Abstract][Full Text] [Related]
30. Aryl hydrocarbon receptor expression and activity in cerebellar granule neuroblasts: implications for development and dioxin neurotoxicity.
Williamson MA; Gasiewicz TA; Opanashuk LA
Toxicol Sci; 2005 Feb; 83(2):340-8. PubMed ID: 15537747
[TBL] [Abstract][Full Text] [Related]
31. Discovery and Mechanistic Characterization of a Select Modulator of AhR-regulated Transcription (SMAhRT) with Anti-cancer Effects.
O'Donnell EF; Jang HS; Liefwalker DF; Kerkvliet NI; Kolluri SK
Apoptosis; 2021 Jun; 26(5-6):307-322. PubMed ID: 33893898
[TBL] [Abstract][Full Text] [Related]
32. Luteolin, an aryl hydrocarbon receptor ligand, suppresses tumor metastasis in vitro and in vivo.
Feng J; Zheng T; Hou Z; Lv C; Xue A; Han T; Han B; Sun X; Wei Y
Oncol Rep; 2020 Nov; 44(5):2231-2240. PubMed ID: 33000272
[TBL] [Abstract][Full Text] [Related]
33. Invasion and migration of MDA-MB-231 cells are inhibited by block of AhR and NFAT: role of AhR/NFAT1/β4 integrin signaling.
Shadboorestan A; Tarfiei GA; Montazeri H; Sepand MR; Zangooei M; Khedri A; Ostad SN; Ghahremani MH
J Appl Toxicol; 2019 Feb; 39(2):375-384. PubMed ID: 30294794
[TBL] [Abstract][Full Text] [Related]
34. Role of GAC63 in transcriptional activation mediated by the aryl hydrocarbon receptor.
Chen YH; Beischlag TV; Kim JH; Perdew GH; Stallcup MR
J Biol Chem; 2006 May; 281(18):12242-7. PubMed ID: 16513642
[TBL] [Abstract][Full Text] [Related]
35. DEHP mediates drug resistance by directly targeting AhR in human breast cancer.
Hsieh TH; Hsu CY; Yang PJ; Chiu CC; Liang SS; Ou-Yang F; Kan JY; Hou MF; Wang TN; Tsai EM
Biomed Pharmacother; 2022 Jan; 145():112400. PubMed ID: 34801851
[TBL] [Abstract][Full Text] [Related]
36. Antiproliferative effect of 2-Hydroxy-6-tridecylbenzoic acid from ginkgo biloba sarcotestas through the aryl hydrocarbon receptor pathway in triple-negative breast cancer cells.
Zhou D; Jiang C; Fu C; Chang P; Yang B; Wu J; Zhao X; Ma S
Nat Prod Res; 2020 Mar; 34(6):893-897. PubMed ID: 30445863
[TBL] [Abstract][Full Text] [Related]
37. The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy.
Zhang S; Lei P; Liu X; Li X; Walker K; Kotha L; Rowlands C; Safe S
Endocr Relat Cancer; 2009 Sep; 16(3):835-44. PubMed ID: 19447902
[TBL] [Abstract][Full Text] [Related]
38. NAD(P)-dependent steroid dehydrogenase-like is involved in breast cancer cell growth and metastasis.
Yoon SH; Kim HS; Kim RN; Jung SY; Hong BS; Kang EJ; Lee HB; Moon HG; Noh DY; Han W
BMC Cancer; 2020 May; 20(1):375. PubMed ID: 32366230
[TBL] [Abstract][Full Text] [Related]
39. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.
D'Amato NC; Rogers TJ; Gordon MA; Greene LI; Cochrane DR; Spoelstra NS; Nemkov TG; D'Alessandro A; Hansen KC; Richer JK
Cancer Res; 2015 Nov; 75(21):4651-64. PubMed ID: 26363006
[TBL] [Abstract][Full Text] [Related]
40. Ah receptor- and TCDD-mediated liver tumor promotion: clonal selection and expansion of cells evading growth arrest and apoptosis.
Bock KW; Köhle C
Biochem Pharmacol; 2005 May; 69(10):1403-8. PubMed ID: 15857604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
